awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37783623-09ABF99A-3893-405E-918C-4D69F7E86DA5
Q37783623-09ABF99A-3893-405E-918C-4D69F7E86DA5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37783623-09ABF99A-3893-405E-918C-4D69F7E86DA5
Early oncology clinical trial design in the era of molecular-targeted agents.
P2860
Q37783623-09ABF99A-3893-405E-918C-4D69F7E86DA5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37783623-09ABF99A-3893-405E-918C-4D69F7E86DA5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9d18522eed5d5221d81782c7d0a50ee4c1c8f2de
P2860
Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types.